December 1, 2017 / 7:21 AM / 17 days ago

BRIEF-Oasmia Pharmaceutical Q2 operating loss shrinks

Dec 1 (Reuters) - Oasmia Pharmaceutical Ab:

* OASMIA PHARMACEUTICAL AB Q2 ‍CONSOLIDATED NET SALES AMOUNTED TO TSEK 1,651 COMPARED TO TSEK 56 IN THE SECOND QUARTER THE PREVIOUS YEAR ​

* OASMIA PHARMACEUTICAL AB Q2 ‍OPERATING LOSS WAS TSEK 22,129 COMPARED TO TSEK 35,867 IN THE SECOND QUARTER THE PREVIOUS YEAR ​ Source text for Eikon: Further company coverage: (Reporting by Stockholm Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below